SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN FRONT-LINE MEDICAL AND NON-MEDICAL STAFF AT THE JORDAN MEDICAL SERVICES, CAMEROON: DESCRIPTIVE CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.53555/nnpbs.v8i4.1206Keywords:
Seroprevalence, Health Care Workers, Non-Healthcare Workers, SARS-CoV 2, CameroonAbstract
Introduction: Health care personnel on the front line of the COVID-19 pandemic represent a source of transmission. The aim of our study was to assess the seroprevalence of anti-SRAS-Cov-2 antibodies in nursing and non-healthcare staff at the Jordan Medical Services (JMS).
Materials and method: We conducted a descriptive cross-sectional study of JMS staff during April 2021 recruited consecutively after obtaining their informed consent. Immunoglobulin G and M were detected using the Panbio TM COVID-19 IgG/IgM kit. The data collected were analysed using SPSS version 21 software. The Chi-square test was used with a statistical significance of p<0.05.
Results: Of the 170 participants, the most represented age group was [30-40[ years (86, 50.6%) with a female participation rate of 55.9% (95) and a predominance of paramedical staff (90, 52.9%). The seroprevalence of COVID-19 was 6.5% (11) for IgM and 44.7% (76) for IgG. The proportion of paramedical staff who were IgG positive for COVID-19 was statistically significantly higher than that of medical and administrative staff, at 52.2% (p = 0.037). On the other hand, the proportion of participants with a history of COVID-19 positive for IgG was statistically higher than that of the others, at 61.5% (p = 0.016).
Conclusion: Seroprevalence of COVID-19 is high among health care and non-health care personnel, with paramedical personnel and history of COVID-19 as associated factors.
References
Juma CA, Mushabaa NK, Abdu Salam F, Ahmadi A, Lucero-Prisno DE. COVID-19: The Current Situation in the Democratic Republic of Congo. Am J Trop Med Hyg. déc 2020;103(6):2168 70.
Suivez la propagation de la COVID-19 à travers le monde [Internet]. Le Devoir. [Cité 18 oct 2021]. Disponible sur : https://www.ledevoir.com/documents/special/20-03_covid19-carte-dynamique/index.html
Atténuer l’impact de la COVID-19 sur les services de santé essentiels, OMS, 05 novembre 2020.
To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. 1 mai 2020;20(5):565 74.
Elsevier. Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19) [Internet]. Elsevier Connect. [Cité 20 oct 2021]. Disponible sur : https://www.elsevier.com/fr-fr/connect/psy/les-professionnels-de-sante-face-a-la-pandemie-de-la-maladie-a-coronavirus-covid-19
Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jiménez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nature Communications [Internet]. 2020 [Cité 12 oct 2021];11. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343863/
Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.
Etyang AO, Lucinde R, Karanja H, Kalu C, Mugo D, Nyagwange J, et al. Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya. Clin Infect Dis. 24 avr 2021 ; ciab346.
Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.
Olatunde Olayanju, Olabisi Bamidele, Fabian Edem, Bola Eseile, Abimbola Amoo, Jude Nwaokenye, Chioma Udeh, Gabriel Oluwole, Gabriel Odok, and Nnaemeka Awah. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria [Internet]. [Cité 19 juill 2021]. Disponible sur : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790104/
Haoud K, Mellali S, La phytothérapie et les produits naturels au secours de la médecine conventionnelle dans le traitement et la prévention de la COVID-19, Algerian Journal of Health Sciences.vol. 03 num. 03 (2021) 79-87.
Chen H, Zhang X, Liu W, Xue M, Liao C, Huang Z, et al. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients. Int Immunopharmacol. févr 2021; 91:107325.
Cherif K, Ernandes H, Hannachi S, Chtourou S, Abid R, Ben Moussa M, Besghaier H, Bellaaj R, Battikh R, COVID-19 chez le personnel de santé travaillant à l’Hôpital Militaire de Tunis, STPI et SPILF, 2021, P140.
Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. The Lancet. 2021; 397(10286):1725–35.
OMS, Éléments à prendre en considération lors de la mise en œuvre et de l’ajustement des mesures de santé publique et des mesures sociales dans le cadre de l’épidémie de COVID-19, Orientations provisoires, 14 juin 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Pharmacy & Biological Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Terms & Condition
Submission -
Author can submit the manuscript through our online submission process or email us at the designated email id in contact details.
The other mode of submission not accepted than online and email.
Before submission please read the submission guidelines.
NN Publication accepts only article submitted in pdf/doc/docx/rtf file format. Another format except given file formats will no be considered .
Author will be responsible for the error mistakes in the submission files. The minor changes can be done without any cost after publication. But for major changes NN Publication may charges you the editing charges.
Publication (Online) -
The online publication is scheduled on last date of every month, but it can be delayed by 24 to 48 hours due to editorial process if huge number of articles comes to publish in single issue.
Automatic notificatation email will be sent to the all users on publication of an issue, so its author’s duty to check their email inbox or SPAM folder to get this notification.
After publication of article author can not withdraw their article.
If editor’s found any issue after publication of article then the NN Publication have the authority to remove the article from online website.
No refund will be provided after online publication of article.
Publication (Print) -
The print copy publication are sent as per the author’s request after 2 weeks of online publication of that issue.
NN Publication will ship the article by India Post and provide the consignment number on dispatch of print copy.
NN Publication follows all the guidelines of delivery provided by IndiaPost and hence not responsible for delay in delivery due to any kind of reasons.
Refund of hard copy will not be provided after dispatch or print of the journal.
NN Publication will be responsible for raise a complain if there is any issue occurs in delivery, but still will not be responsible for providing the refund.
NN Publication will be responsible to resend the print copy only and only if the print copy is lost or print copy is damaged in delivery / or there is delay more than 6 months.
According to India Post the delivery should be completed with in 1-3 weeks after dispatch of articles.
Privacy Policy-
NN Publication uses the email ids of authors and editors and readers for sending editorial or publication notification only, we do not reveal or sell the email ids to any other website or company.
